220 related articles for article (PubMed ID: 12169771)
1. Inhibitory control of growth hormone secretion by somatostatin in rat pituitary GC cells: sst(2) but not sst(1) receptors are coupled to inhibition of single-cell intracellular free calcium concentrations.
Cervia D; Petrucci C; Bluet-Pajot MT; Epelbaum J; Bagnoli P
Neuroendocrinology; 2002 Aug; 76(2):99-110. PubMed ID: 12169771
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells.
Strowski MZ; Dashkevicz MP; Parmar RM; Wilkinson H; Kohler M; Schaeffer JM; Blake AD
Neuroendocrinology; 2002 Jun; 75(6):339-46. PubMed ID: 12065886
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.
Petrucci C; Cervia D; Buzzi M; Biondi C; Bagnoli P
Br J Pharmacol; 2000 Feb; 129(3):471-84. PubMed ID: 10711345
[TBL] [Abstract][Full Text] [Related]
4. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
Lamberts SW; den Holder F; Hofland LJ
Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
[TBL] [Abstract][Full Text] [Related]
5. Identification of somatostatin receptors controlling growth hormone and thyrotropin secretion in the chicken using receptor subtype-specific agonists.
Geris KL; de Groef B; Rohrer SP; Geelissen S; Kühn ER; Darras VM
J Endocrinol; 2003 May; 177(2):279-86. PubMed ID: 12740016
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists.
Cervia D; Zizzari P; Pavan B; Schuepbach E; Langenegger D; Hoyer D; Biondi C; Epelbaum J; Bagnoli P
Neuropharmacology; 2003 Apr; 44(5):672-85. PubMed ID: 12668053
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
[TBL] [Abstract][Full Text] [Related]
8. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
Torronteras R; Gracia-Navarro F; Elsaesser F
Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin blocks the potentiation of TRH-induced TSH secretion from perifused pituitary fragments and the change in intracellular calcium concentrations from dispersed pituitary cells elicited by prepro-TRH (PS4) or by tri-iodothyronine.
Roussel JP; Grazzini E; Astier H
J Mol Endocrinol; 1997 Aug; 19(1):87-97. PubMed ID: 9278864
[TBL] [Abstract][Full Text] [Related]
10. Species differences between male rat and ram pituitary somatostatin receptors involved in the inhibition of growth hormone secretion.
Briard N; Dutour A; Epelbaum J; Sauze N; Slama A; Oliver C
Eur J Endocrinol; 1997 Nov; 137(5):545-55. PubMed ID: 9405036
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic octreotide treatment on GH secretory dynamics and tumor growth in rats bearing an ectopic somatotroph (GC) tumor.
Mounier F; Bluet-Pajot MT; Viollet C; Bertherat J; Timsit J; Tannenbaum GS; Epelbaum J
J Neuroendocrinol; 1995 Aug; 7(8):645-51. PubMed ID: 8704739
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.
Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD
Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester and phospholipase C-induced growth hormone secretion from pituitary somatotroph adenoma cells in culture: effects of somatostatin, bromocriptine, and pertussis toxin.
Ikuyama S; Nawata H; Kato K; Natori S; Ibayashi H
J Clin Endocrinol Metab; 1987 Mar; 64(3):572-7. PubMed ID: 2880863
[TBL] [Abstract][Full Text] [Related]
14. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
[TBL] [Abstract][Full Text] [Related]
15. Homologous upregulation of sst2 somatostatin receptor expression in the rat arcuate nucleus in vivo.
Tannenbaum GS; Turner J; Guo F; Videau C; Epelbaum J; Beaudet A
Neuroendocrinology; 2001 Jul; 74(1):33-42. PubMed ID: 11435756
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin and its receptors contribute in a tissue-specific manner to the sex-dependent metabolic (fed/fasting) control of growth hormone axis in mice.
Córdoba-Chacón J; Gahete MD; Castaño JP; Kineman RD; Luque RM
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E46-54. PubMed ID: 20943754
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-14 actions on dopamine- and pituitary adenylate cyclase-activating polypeptide-evoked Ca2+ signals and growth hormone secretion.
Yunker WK; Chang JP
J Neuroendocrinol; 2004 Aug; 16(8):684-94. PubMed ID: 15271061
[TBL] [Abstract][Full Text] [Related]
18. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
[TBL] [Abstract][Full Text] [Related]
19. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
Bertherat J; Chanson P; Dewailly D; Enjalbert A; Jaquet P; Kordon C; Peillon F; Timsit J; Epelbaum J
Horm Res; 1992; 38(1-2):94-9. PubMed ID: 1306525
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release.
Cervia D; Fiorini S; Pavan B; Biondi C; Bagnoli P
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):200-9. PubMed ID: 11882916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
